These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15663550)

  • 1. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
    Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
    Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet apheresis for extreme thrombocytosis in an 11-year-old girl with CML.
    McCarthy LJ; Graves VL; Eigen H; McGuire WA
    Transfus Med; 1991 Sep; 1(3):187-9. PubMed ID: 9259847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet apheresis for digital gangrene due to thrombocytosis in chronic myeloid leukaemia.
    Win N; Mitchell DC
    Clin Lab Haematol; 2001 Feb; 23(1):65-6. PubMed ID: 11422234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic myelogenous leukemia with marked thrombocytosis].
    Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
    Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
    Baron BW; Mick R; Baron JM
    Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
    Koike G; Otsuka T; Shibuya T; Niho Y
    Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Report of 8 cases of bcr-abl gene positive thrombocytosis and review of the literature].
    Lin FR; Wang Y; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):528-31. PubMed ID: 15569529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Chronic Myeloid Leukemia Presenting With Extreme Thrombocytosis Simulating Essential Thrombocythemia.
    Boklan JL; Walsh AM; de la Maza MC; Su LL; Nizzi FA; Schafernak KT
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):456-457. PubMed ID: 29668550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia.
    Campiotti L; Grandi AM; Biotti MG; Ultori C; Solbiati F; Codari R; Venco A
    Am J Hematol; 2007 Mar; 82(3):231-3. PubMed ID: 17022045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characteristics of the postsplenectomy hyperthrombocytic syndrome in patients with chronic myeloleukemia].
    Berliner TB; Miasnikov AA; Kheĭfets LM; Polezhaev IuN
    Ter Arkh; 1991; 63(7):56-8. PubMed ID: 1788810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocytosis in a Ph1 positive chronic myeloproliferative syndrome. Chronic myeloid leukemia or essential thrombocythemia].
    López L; Alonso F; Pascual T
    Sangre (Barc); 1992 Aug; 37(4):299. PubMed ID: 1514146
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role for platelet apheresis for post-liver transplant thrombocytosis complicating portal vein thrombosis.
    Au WY; Liu CL; Lo CM; Fan ST; Ma SK
    J Clin Apher; 2004; 19(4):192-6. PubMed ID: 15597348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.
    Almeida-Dias R; Garrote M; Cid J; Mustieles MJ; Alba C; Lozano M
    J Clin Apher; 2019 Aug; 34(4):503-506. PubMed ID: 30624802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of thrombocytosis by plateletpheresis using a cell separator.
    Beard ME; Blacklock HA; Varcoe AR
    N Z Med J; 1980 Feb; 91(654):136-8. PubMed ID: 6929973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing uncontrolled postsplenectomy reactive thrombocytosis in idiopathic thrombocytopenic purpura: role of thrombocytapheresis.
    Das SS; Bhattacharya S; Sen S
    Transfus Apher Sci; 2013 Oct; 49(2):171-3. PubMed ID: 23871583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
    Jootar S
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytosis--report of a case.
    Thomas M; Pavithran K; Salil ; Somarajan A
    J Assoc Physicians India; 2000 Apr; 48(4):441-2. PubMed ID: 11273186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.
    Boddu P; Falchi L; Hosing C; Newberry K; Bose P; Verstovsek S
    Leuk Res; 2017 Jul; 58():14-22. PubMed ID: 28380402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic myeloid leukemia--a rare cause of labyrinth apoplexy].
    Woldag K; Schwarzer A
    Laryngorhinootologie; 1996 Apr; 75(4):247-9. PubMed ID: 8688132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.